4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000947871-25-001087
Director sold 1,875 shares at an average $44.49 ($83,428)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. Director | 2025-12-17 | Sale 10b5-1 | −900 | $44.50 | $40,050 | 3,595,986 | I |
| Thompson Peter A. Director | 2025-12-18 | Sale 10b5-1 | −100 | $44.49 | $4,449 | 3,595,886 | I |
| Thompson Peter A. Director | 2025-12-19 | Sale 10b5-1 | −875 | $44.49 | $38,929 | 3,595,011 | I |
| Open-market sales · 1,875 sh · avg $44.49 · $83,428 | |||||||
Loading xslF345X05/ownership.xml…